OPTIMER PHARMACEUTICALS INC: 10-Q filed 2013-08-07

Name: OPTIMER PHARMACEUTICALS INC: 10-Q filed 2013-08-07
Creator: OPTIMER PHARMACEUTICALS INC

What OPTIMER PHARMACEUTICALS INC reported in its quarterly report filed 2013-08-07 (fiscal Q2 2013): 29 published measures, 76 facts as tagged in accession 0001104659-13-060943.

This filing

Form: 10-Q (quarterly report)
Filed: 2013-08-07
Fiscal period: fiscal Q2 2013
Accession: 0001104659-13-060943 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All OPTIMER PHARMACEUTICALS INC filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2013-06-30	121,246,466	USD
At 2012-12-31	159,427,322	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2013-06-30	89,075,530	USD
At 2012-12-31	130,810,220	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2013-06-30	72,844,663	USD
At 2012-12-31	119,444,586	USD
At 2012-06-30	99,703,307	USD
At 2011-12-31	31,787,512	USD

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2013-01-01 to 2013-06-30	605,166	USD	181
2012-01-01 to 2012-06-30	1,721,109	USD	182

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2013-04-01 to 2013-06-30	20,069,090	USD	91
2013-01-01 to 2013-06-30	39,504,584	USD	181
2012-04-01 to 2012-06-30	49,757,572	USD	91
2012-01-01 to 2012-06-30	64,140,219	USD	182

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2013-06-30	-310,181,449	USD
At 2012-12-31	-251,979,413	USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2013-06-30	4,334,860	USD
At 2012-12-31	4,338,720	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2013-01-01 to 2013-06-30	7,118,650	USD	181
2012-01-01 to 2012-06-30	7,058,709	USD	182

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2013-04-01 to 2013-06-30	-27,119,453	USD	91
2013-01-01 to 2013-06-30	-58,610,377	USD	181
2012-04-01 to 2012-06-30	328,330	USD	91
2012-01-01 to 2012-06-30	-34,245,115	USD	182

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2013-06-30	114,957,134	USD
At 2012-12-31	152,015,563	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2013-06-30	30,094,256	USD
At 2012-12-31	26,787,739	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2013-06-30	2,726,849	USD
At 2012-12-31	7,166,127	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2013-06-30	7,684,902	USD
At 2012-12-31	7,119,089	USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2013-06-30	26,916,501	USD
At 2012-12-31	15,061,771	USD

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

Period	Value	Unit	Days
2013-04-01 to 2013-06-30	30,520,599	USD	91
2013-01-01 to 2013-06-30	64,520,332	USD	181
2012-04-01 to 2012-06-30	28,856,929	USD	91
2012-01-01 to 2012-06-30	54,379,211	USD	182

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2013-04-01 to 2013-06-30	10,939,649	USD	91
2013-01-01 to 2013-06-30	20,825,834	USD	181
2012-04-01 to 2012-06-30	11,557,217	USD	91
2012-01-01 to 2012-06-30	22,625,184	USD	182

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2013-06-30	48,867,868	shares
At 2012-12-31	47,791,531	shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2013-06-30	398,479	USD
At 2012-12-31	464,170	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2013-06-30	1,063,629	USD
At 2012-12-31	1,362,196	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2013-06-30	27,246,589	USD
At 2012-12-31	19,165,362	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2013-06-30	1,939,938	USD
At 2012-12-31	3,442,717	USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2013-04-01 to 2013-06-30	-26,870,337	USD	91
2013-01-01 to 2013-06-30	-58,202,036	USD	181
2012-04-01 to 2012-06-30	-296,204	USD	91
2012-01-01 to 2012-06-30	-11,497,002	USD	182

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2013-04-01 to 2013-06-30	-26,883,200	USD	91
2013-01-01 to 2013-06-30	-58,267,727	USD	181
2012-04-01 to 2012-06-30	-177,625	USD	91
2012-01-01 to 2012-06-30	-10,365,029	USD	182

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2013-04-01 to 2013-06-30	-26,870,337	USD	91
2013-01-01 to 2013-06-30	-58,202,036	USD	181
2012-04-01 to 2012-06-30	-296,204	USD	91
2012-01-01 to 2012-06-30	-11,216,658	USD	182

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2013-01-01 to 2013-06-30	516,437	USD	181
2012-01-01 to 2012-06-30	390,874	USD	182

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2013-04-01 to 2013-06-30	249,116	USD	91
2013-01-01 to 2013-06-30	408,341	USD	181
2012-04-01 to 2012-06-30	44,318	USD	91
2012-01-01 to 2012-06-30	120,705	USD	182

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2013-01-01 to 2013-06-30	9,385,558	USD	181
2012-01-01 to 2012-06-30	4,255,338	USD	182

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2013-01-01 to 2013-06-30	565,813	USD	181
2012-01-01 to 2012-06-30	-1,251,213	USD	182

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2013-01-01 to 2013-06-30	11,854,730	USD	181
2012-01-01 to 2012-06-30	4,014,732	USD	182

Inspect the source

Entity: OPTIMER PHARMACEUTICALS INC / CIK 0001142576
Captured: 2026-09-22 19:40 UTC
SEC response SHA-256: 02b84c6fe0b8b093900a9b90f35735ca228f3a27ecd2d0df94f08434ff919092

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001142576.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))